Sarizotan in Parkinson Patients With L-dopa-induced Dyskinesia

PHASE2CompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

July 31, 2002

Study Completion Date

July 31, 2003

Conditions
Parkinson's DiseaseDyskinesia
Interventions
DRUG

Sarizotan HCl

Trial Locations (51)

Unknown

Fountain Valley

Sunnyvale

Miami

Tampa

Atlanta

Chicago

Augusta

Boston

Kansas City

Brooklyn

New York

Cincinnati

Columbus

Philadelphia

Pawtucket

Memphis

Houston

Leuven

Sofia

Edmonton

Saskatoon

Vancouver

Clermont-Ferrand

Marseille

Nantes

Paris

Toulouse

Bochum

Dresden

Leipzig

Lübeck

München

Ulm

Wiesbaden

Budapest

Győr

Miskolc

Coimbra

Lisbon

Bucaresti

Constanța

Târgu Mureş

George

Plumstead Cape Town

Rosebank

Sunninghill

Wilgers

Cambridge

Newcastle

Nottingham

Sheffield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

EMD Serono

INDUSTRY

NCT00314288 - Sarizotan in Parkinson Patients With L-dopa-induced Dyskinesia | Biotech Hunter | Biotech Hunter